VCheng
ELITE MEMBER
- Joined
- Sep 29, 2010
- Messages
- 48,460
- Reaction score
- 57
- Country
- Location
@mmr
https://www.bloomberg.com/news/arti...re-more-than-1-000-u-s-companies-out-of-china
Gives idea of how existing presence helps to move more (seed---->sapling --->large plant----> tree):
India expects to win over U.S. companies involved in healthcare products and devices, and is in talks with Medtronic Plc and Abbott Laboratories on relocating their units to the country, an official said. Medtronic spokesman Ben Petok and Abbott spokeswoman Darcy Ross didn’t immediately respond to emails seeking comment.
Both Medtronic and Abbott have a presence in India, which may make it easier for them to move their China supply chains to the country, according to an official. They’re based out of financial center Mumbai and already work with large Indian hospital groups.
(Rest of article provides more context, details and challenges)
========
It is often about getting leg in the door early....so you have place at table later.
Thats why BD and others have to improve their ease of doing business as first move to sustainably get the seeds and saplings for 10 - 20 years later (or even longer) to grow lot more when opportunity arrives. It does not come overnight, esp the final tier stuff that provides the most value/wealth to economy.
@Krptonite @BL33D @bluesky @leonblack08 @Jungibaaz @Naofumi @Chak Bamu @VCheng
The two things that supply chain managers look for are reliability of the sources and the consistency of governmental policies since they tend to take a longer time-horizon into account when developing new chains.
India seems to be well-placed to try for a slice of the business that is looking to divest from China partly in order to increase the diversity of their suppliers to avoid single-supplier vulnerabilities as the recent virus crisis has shown. In fact, other countries in South Asia and the Far East will be making competitive bids to get their own share of this possible bonanza.